NARCOLEPSY TYPE 2
Clinical trials for NARCOLEPSY TYPE 2 explained in plain language.
Never miss a new study
Get alerted when new NARCOLEPSY TYPE 2 trials appear
Sign up with your email to follow new studies for NARCOLEPSY TYPE 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for keeping sleep disorders in check over the long haul
Disease control Recruiting nowThis study looks at the long-term safety and how well ALKS 2680 works for people with narcolepsy type 1, type 2, or idiopathic hypersomnia. About 256 adults who finished a previous ALKS 2680 study will take the tablet and be monitored for side effects and improvements in daytime …
Matched conditions: NARCOLEPSY TYPE 2
Phase: PHASE2, PHASE3 • Sponsor: Alkermes, Inc. • Aim: Disease control
Last updated May 17, 2026 08:55 UTC
-
New orexin mimic aims to wake up sleepy patients
Symptom relief Recruiting nowThis study tests a new drug called ORX750 (cleminorexton) that mimics a natural brain protein (orexin) to help people stay awake. It includes 248 adults with narcolepsy type 1, type 2, or idiopathic hypersomnia. The main goals are to check safety and see if the drug reduces dayti…
Matched conditions: NARCOLEPSY TYPE 2
Phase: PHASE2 • Sponsor: Centessa Pharmaceuticals (UK) Limited • Aim: Symptom relief
Last updated May 17, 2026 08:46 UTC
-
New sleep drug ORX750 tested for long-term safety in narcolepsy and hypersomnia patients
Symptom relief Recruiting nowThis study looks at the long-term safety and effectiveness of a drug called ORX750 in people with narcolepsy (types 1 and 2) or idiopathic hypersomnia who have already completed a previous ORX750 study. About 90 participants will take the drug and be monitored for side effects an…
Matched conditions: NARCOLEPSY TYPE 2
Phase: PHASE2 • Sponsor: Centessa Pharmaceuticals (UK) Limited • Aim: Symptom relief
Last updated May 12, 2026 13:43 UTC
-
New pill mimics brain chemical to fight daytime sleepiness
Symptom relief Recruiting nowThis study tests a new drug called TAK-360 for people with narcolepsy type 2, a condition that causes severe daytime sleepiness. The drug acts like a natural brain chemical (orexin) that helps keep you awake. About 88 adults will receive either TAK-360 or a placebo to see if the …
Matched conditions: NARCOLEPSY TYPE 2
Phase: PHASE2 • Sponsor: Takeda • Aim: Symptom relief
Last updated May 12, 2026 13:40 UTC
-
New pill aims to fight daytime sleepiness in narcolepsy
Symptom relief Recruiting nowThis study tests a new medication called ALKS 2680 to see if it can reduce daytime sleepiness and other symptoms in adults with narcolepsy type 2. About 176 participants will receive either the study drug or a placebo pill. The main goal is to measure how well they can stay awake…
Matched conditions: NARCOLEPSY TYPE 2
Phase: PHASE3 • Sponsor: Alkermes, Inc. • Aim: Symptom relief
Last updated May 06, 2026 16:14 UTC
-
Spain launches first nationwide narcolepsy census
Knowledge-focused Recruiting nowThis study aims to find out how many people in Spain have been diagnosed with narcolepsy type 1 or type 2, and how many new cases are diagnosed each year. Researchers will review medical records from hospitals across Spain to count patients and understand patterns. The study does…
Matched conditions: NARCOLEPSY TYPE 2
Sponsor: Takeda • Aim: Knowledge-focused
Last updated May 13, 2026 15:59 UTC